Avience Biomedicals (NSE:AVIENCE) Accounts Payable: ₹67.5 Mil (As of Jan. 2026)


NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
5 GF Score
Price ₹414.95
View Full Analysis

What is Avience Biomedicals Accounts Payable?

Avience Biomedicals NSE:AVIENCE 5 Accounts Payable is ₹67.5 Mil as of Jan. 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100.

Avience Biomedicals's Accounts Payable for the quarter that ended in Jan. 2026 was ₹67.5 Mil.

Avience Biomedicals's quarterly Accounts Payable increased from Mar. 2024 (₹55.5 Mil) to Mar. 2025 (₹72.7 Mil) but then declined from Mar. 2025 (₹72.7 Mil) to Jan. 2026 (₹67.5 Mil).

Avience Biomedicals's annual Accounts Payable increased from Mar. 2023 (₹12.7 Mil) to Mar. 2024 (₹55.5 Mil) and increased from Mar. 2024 (₹55.5 Mil) to Mar. 2025 (₹72.7 Mil).

Avience Biomedicals Accounts Payable Related Terms

Avience Biomedicals Accounts Payable Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals Accounts Payable Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
Accounts Payable
12.72 55.49 72.68

Avience Biomedicals Quarterly Data
Mar23 Mar24 Mar25 Jan26
Accounts Payable 12.72 55.49 72.68 67.54
NSE:AVIENCE
5GF Score
Avience Biomedicals Ltd NSE:AVIENCE
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ₹67.5 Mil mean?
Avience Biomedicals (NSE:AVIENCE) has a Accounts Payable of ₹67.5 Mil as of Jan. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Avience Biomedicals and its competitors.
Is Avience Biomedicals' Accounts Payable too high?
Avience Biomedicals' current Accounts Payable is ₹67.5 Mil. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' Accounts Payable compare to ABT and SYK?
Avience Biomedicals' Accounts Payable of ₹67.5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Avience Biomedicals and its competitors. Avience Biomedicals's current Accounts Payable is ₹67.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current Accounts Payable of ₹67.5 Mil. The current Accounts Payable is ₹67.5 Mil. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current Accounts Payable is ₹67.5 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score

Get the complete analysis for NSE:AVIENCE

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.95
Price